PER 2.67% 7.3¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-174

  1. 236 Posts.
    lightbulb Created with Sketch. 59
    Of course not, there is inherent risks with all stocks but thats not what you asked and certainly not what ANP have ever come out and stated.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.